Indies Pharma Jamaica Past Earnings Performance

Past criteria checks 2/6

Indies Pharma Jamaica has been growing earnings at an average annual rate of 9.4%, while the Healthcare industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 9.3% per year. Indies Pharma Jamaica's return on equity is 17.3%, and it has net margins of 19%.

Key information

9.4%

Earnings growth rate

8.6%

EPS growth rate

Healthcare Industry Growth	-2.9%
Revenue growth rate	9.3%
Return on equity	17.3%
Net Margin	19.0%
Last Earnings Update	31 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Indies Pharma Jamaica makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

JMSE:INDIES Revenue, expenses and earnings (JMD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Jul 24	1,136	216	344
30 Apr 24	1,139	256	344
31 Jan 24	1,069	217	342
31 Oct 23	1,055	213	312
31 Jul 23	997	206	339
30 Apr 23	962	194	300
31 Jan 23	981	230	281
31 Oct 22	937	221	274
31 Jul 22	941	252	276
30 Apr 22	884	222	270
31 Jan 22	836	171	262
31 Oct 21	847	168	244
31 Jul 21	833	152	251
30 Apr 21	791	159	240
31 Jan 21	796	215	230
31 Oct 20	766	207	246
31 Jul 20	719	177	265
30 Apr 20	769	161	295
31 Jan 20	755	124	314
31 Oct 19	729	131	295
31 Jul 19	763	153	304
30 Apr 19	696	150	269
31 Jan 19	653	143	224
31 Oct 18	636	120	210
31 Jul 18	622	123	221
30 Apr 18	647	135	191
31 Jan 18	635	135	190
31 Oct 17	620	137	186
31 Oct 16	587	79	248

Quality Earnings: INDIES has high quality earnings.

Growing Profit Margin: INDIES's current net profit margins (19%) are lower than last year (20.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: INDIES's earnings have grown by 9.4% per year over the past 5 years.

Accelerating Growth: INDIES's earnings growth over the past year (4.5%) is below its 5-year average (9.4% per year).

Earnings vs Industry: INDIES earnings growth over the past year (4.5%) did not outperform the Healthcare industry 20.1%.

Indies Pharma Jamaica Past Earnings Performance

Past criteria checks 2/6

Key information

Recent past performance updates

Third quarter 2024 earnings released: EPS: JA$0.03 (vs JA$0.06 in 3Q 2023)

Second quarter 2024 earnings released: EPS: JA$0.053 (vs JA$0.02 in 2Q 2023)

First quarter 2024 earnings released: EPS: JA$0.047 (vs JA$0.044 in 1Q 2023)

Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022)

Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022)

Third quarter 2023 earnings released: EPS: JA$0.06 (vs JA$0.05 in 3Q 2022)

Recent updates

Third quarter 2024 earnings released: EPS: JA$0.03 (vs JA$0.06 in 3Q 2023)

Investor sentiment improves as stock rises 21%

Second quarter 2024 earnings released: EPS: JA$0.053 (vs JA$0.02 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Indies Pharma Jamaica Limited, Annual General Meeting, May 29, 2024

First quarter 2024 earnings released: EPS: JA$0.047 (vs JA$0.044 in 1Q 2023)

Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022)

Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Insufficient new directors

Third quarter 2023 earnings released: EPS: JA$0.06 (vs JA$0.05 in 3Q 2022)

Second quarter 2023 earnings released: EPS: JA$0.02 (vs JA$0.05 in 2Q 2022)

Investor sentiment improves as stock rises 19%

Upcoming dividend of JA$11.33 per share at 3.4% yield

Investor sentiment improves as stock rises 26%

First quarter 2023 earnings released: EPS: JA$0.04 (vs JA$0.04 in 1Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment deteriorates as stock falls 22%

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: JA$0.05 (vs JA$0.03 in 3Q 2021)

Second quarter 2022 earnings released: EPS: JA$0.05 (vs JA$0.01 in 2Q 2021)

Upcoming dividend of JA$0.11 per share

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JA$0.01 (vs JA$0.04 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS JA$0.02 (vs JA$0.05 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JA$0.04 (vs JA$0.03 in 1Q 2020)

Upcoming Dividend of JA$0.11 Per Share

New 90-day high: JA$2.89

Full year 2020 earnings released: EPS JA$0.15 (vs JA$0.12 in FY 2019)

Investor sentiment improved over the past week

New 90-day low: JA$2.31

Full year 2020 earnings released: EPS JA$0.15

New 90-day low: JA$2.43

Indies Pharma Jamaica Limited Announces Appointment of Directors

Third quarter earnings released

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies